300 and pH 7, and is prevented by protease inhibitors. The ability of the small fragments to activate adenylate cyclase is reversed by anti-holotoxin, but not anticholeragenoid, antibodies. These fragments require NAD for the activation of adenylate cyclase and are fully active after heating at 900 for 5 min (pH 7).
Field suggested that the biological functions of cholera toxin might be mediated by adenylate cyclase [ATP:pyrophosphate-lyase (cyclizing), EC 4.6.1.1] activation (1) . Subsequently, Gill found that NAD is necessary for this activation by the holotoxin (2) . A number of studies have suggested that the holotoxin is composed of four to six identical B subunits with molecular weights of 9,500-14,000 and an A subunit with a molecular weight of about 28,000 (3, 4) . The A subunit can be further dissociated by sulfhydryl reagents into Al (20,000-24,000 daltons) and A2 (4000-7500 daltons) subunits (5) .
There is agreement that the activation of adenylate cyclase by cholera toxin is exclusively a function of the A subunit (6) . Concentration of the toxin at the cell surface is accomplished by the B subunits, which are known to bind to a specific monosialoganglioside, GM1 (7) (8) (9) .
Recently we have been studying the interaction of cholera toxin and adenylate cyclase in membrane particles from sarcoma 180 cells. In these cells, as has been found with the avian erythrocyte, NAD is indispensable for the activation of adenylate cyclase by cholera toxin (10, 11) . We have also found that in sarcoma 180 cells the catecholamine receptor can be entirely desensitized by prior exposure to isoproterenol or inactivated by propranolol without diminishing the response to holotoxin (11) .
Here we report that incubation of holotoxin with membrane particles prepared from sarcoma 180 cells gives rise to a variety of fragments, which are capable of activating adenylate cyclase. The smallest of these has an approximate molecular weight of 1400. These fragments originate in cholera toxin, since they can be inactivated by antibody directed against the holotoxin and also they can be prepared from purified A subunit in the presence of sarcoma membrane particles. These [3H]cAMP was isolated by polyethyleneimine cellulose descending thin-layer chromatography (14) . Basal adenylate cyclase activity is in the range of 50-100 pmol/min per mg of protein. Protease activity was evaluated with denatured hemoglobin as substrate (15) . Polyacrylamide (10%) gel electrophoresis was done in 1% sodium dodecyl sulfate (NaDodSO4) (16) . Following exposure of various holotoxin or subunit preparations to membrane particles the particles were routinely removed by centrifugation (100,000 X g, 30 min, 40) prior to subsequent analytical procedures. Density gradient centrifugation was done on a 3.5 ml continuous sucrose gradient (5-20%, wt/vol, in 10 mM Tris-HCl, (+0.1% NaDodSO4, pH 7.4) at 50,000 rpm in a Beckman SW-56 rotor for 16 hr (17) . Upward flow Sephadex G-100 gel filtration (column, 1.5 X 90.3 cm) was done at 250 in 0.2 M formic acid-NH40H (pH 7.5) or 10 mM Tris-HCI buffer (pH 7.5) containing 0.5% NaDodSO4 and 1 mM DTT. Upward flow Sephadex G-75 gel filtration (column, 1.5 X 91.5 cm) was done at 250 in 5% (vol/vol) formic acid. Molecular weight markers were blue dextran 200 (200,000) for the void volume, bovine serum albumin (67,000), hemoglobin (64,000), chymotrypsinogen A (25,000), cytochromne c (12,500), cholera toxin B subunit (9500) (4), glucagon (3460), and bacitracin (1400). In the figures molecular weights of all markers are given in thousands, k. A mixture of 25 mM EDTA, 10 mM N-ethylmaleimide, 1 mM phenylmethylsulfonyl fluoride, and 0.5 mM p-aminobenzamidine (final concentrations given) was used to inhibit protease activity. Protein was determined by the method of Lowry et al. (18) .
RESULTS
Preparation of small fragments from holotoxin; dependence on protease activity
The holotoxin was exposed to sarcoma membrane particles, the particles were removed by centrifugation, and the supernatant was applied to a Sephadex G-100 column. Resulting fractions were analyzed for their ability to activate adenylate cyclase in sarcoma membrane particles (Fig. 1) . We emphasize that: (i) The commercial preparation of holotoxin contains small amounts of stimulatory fragments having molecular weights less than the A subunit. (ii) Exposure of the toxin to sarcoma membrane particles greatly enhances the yield of these small fragments. (Iii) Furthermore, the introduction of a mixture of reagents that collectively inhibit protease activity markedly diminishes the elaboration of these fragments.
We then looked for the optimal conditions necessary for elaboration of these fragments by studying the effect of various pH values and membrane preparation in the presence and absence of NAD and DTT. In addition, we examined the yield of small fragments as a function of time (Fig. 2) . Optimal yields of small fragments were obtained by incubating the holotoxin with membrane particles for 40-60 min at pH 7.4 and 30°. The production of small fragments was negligible at 00. The yield of small fragments was diminished by greater than 80% when holotoxin was incubated with homogenate. The addition of DTT In order to clarify whether these fragments were significantly smaller than Al or were really larger fragments whose emergence from the column had been delayed by nonspecific interactions with Sephadex, we examined other types of separation conditions. The Al subunit was prepared by incubation of holotoxin with NaDodSO4 and DTT followed by Sephadex gel filtration (Fig. 3) . (Although the Al subunit was contaminated with B subunit, it migrated more rapidly than the A subunit in NaDodSO4 polyacrylamide gel electrophoresis.) Most of the NaDodSO4 was then precipitated by cooling at 0°overnight. After the Al subunit was incubated with sarcoma membrane particles, the particles were removed by centrifugation. The resultant supernatant was incubated with DTT and NaDodSO4 and analyzed on Sephadex G-100 in the continued presence of DTT and NaDodSO4. There was a marked increase in the yield of low-molecular-weight fragments which activate adenylate cyclase only when Al was incubated with sarcoma membrane particles (Fig. 3) . In contrast, the apparent molecular weight of Al subunit prepared by Sephadex G-100 gel filtration was not altered by repeat gel filtration in the presence of NaDodSo4.
We then prepared A subunit using gel filtration in the presence of formic acid (Fig. 4) . The A subunit purified in this manner gave a single band on polyacrylamide gel electrophoresis (4). The A subunit was neutralized and incubated with sarcoma membrane particles. The pH was then adjusted to 2.1 with formic acid, the membrane particles were sedimented, and the supernatant was analyzed on Sephadex G-75. Sarcoma membrane particles greatly increased the yield of small, adenylate-cyclase-activating fragments from this A subunit (Fig.  4) . This increase was prevented by the mixture of protease inhibitors.
We emphasize that the small fragments of A subunit that can activate adenylate cyclase appear heterogeneous in size; that the bulk of the fragments produced by the sarcoma membrane particles have an apparent molecular weight inthe 8,000-10,000 Sedimentation behavior of small fragment(s) on a continuous sucrose density gradient; reversal of aggregation by NaDod-S04. Small fragment fraction (300,ul) (see Fig. 2 A, elution volume, 148 ml) was incubated at 40°for 30 min in the presence (0) or absence (0) of 1% NaDodS04 (containing 0.4 mM EDTA, pH 7.5, and 16 mM D'IT), chilled at 00 overnight, and sedimented to remove precipitated NaDodSO4. Resulting supernatants were mixed with hemoglobin and cytochrome c (-NaDodSO4) or cytochrome c alone (+ 0.1% NaDodSO4) as standards, and layered on a 3.5 ml continuous sucrose density gradient. Following centrifugation, the contents were collected from the bottom in 19 equal fractions which were chilled at 00 for 3 hr, centrifuged to remove precipitated NaDodSO4, and examined (10 ,ul aliquots) for adenylate-cyclase-activating ability. range (as judged by elution behavior from Sephadex); and that the smallest fragment that displays adenylate-cyclase-activating ability appears smaller then glucagon (3460 daltons) and has roughly the same size as bacitracin (1400 daltons) (Figs. 1 and  2) . Behavior of small fragments in sucrose density gradients; aggregation reversed by NaDodSO4 The smallest toxin fragments which retained the ability to activate adenylate cyclase were eluted from Sephadex G-100 and sedimented on a continuous sucrose density gradient (5-20%). Under these conditions the small fragments formed aggregates that sedimented more rapidly than hemoglobin. When this procedure was repeated in the presence of NaDodSO4, however, the fragments did not aggregate but sedimented less rapidly than cytochrome c (12,500 daltons) (Fig. 5) .
In addition to the small fragments there is also evidence that the A subunit of the cholera toxin tends to aggregate and loose activity when stored in neutral aqueous solutions at 5°. Activity can be fully restored by exposure to 1% NaDodSO4 (250, 1 hr) and subsequent removal of detergent by cooling at 00 for 3 hr followed by centrifugation. Antigenic and stability properties of small fragments When small fragments were combined with antiholotoxin antibody prior to admixture with membrane particles for assay of adenylate cyclase, they were rendered completely inactive. Antibody directed against the B subunits did not interfere with the activity of small fragments (Table 1) . Small fragments were found to be fully active after heating at pH 7 and 900 for 5 min.
DISCUSSION
Previous work (10) indicated that membranes from sarcoma 180 cell could elaborate macromolecular adenylate cyclase * Fraction of Sephadex G-100 gel filtration (see Fig. 2 , L, 20 min)
were used as follows: control, elution volume (Ve) = 39 ml; holotoxin, Ve = 73 ml; Al, Ve = 110 ml; -12,500, Ve = 125 ml; -3,000, Ve = 148 ml. The concentration of antiholotoxin used reversed adenylate cyclase activation by 10 /g/ml of holotoxin.
The concentration of anticholeragenoid was enough to neutralize from 2 to 5 ig/ml of purified choleragen as assayed by rabbit skin permeability. In each case the antibody was added to the toxin or toxin fragment prior to evaluation of adenylate-cyclaseactivating ability.
activating factor (MCAF) having an apparent molecular weight of 26,000. Further work indicates that these membranes can produce fragments of cholera toxin with molecular weights as low as 1400 which can activate adenylate cyclase. We suggest that the small fragments originate from the A or Al subunits of cholera toxin and not the sarcoma cells because they are inactivated by antibody to holotoxin, need NAD for activation of adenylate cyclase (as do the holotoxin and the A subunit), and are heat stable (as is the A subunit). The commercial holotoxin preparations are contaminated by small amounts of adenylate-cyclase-activating fragments whose quantity is greatly increased by exposure to sarcoma membrane particles. The effect of sarcoma membrane particles is virtually prevented by protease inhibitors. Since the yield of small fragments is greatly increased by membrane particles, and indeed diminished by long incubation (60 min) in the presence of cytoplasm, we suggest that the enzymes responsible for small fragment production are associated with a particulate fraction and that fragment damaging activities are found in the cytoplasm. We emphasize that the apparent smallness of these fragments is not an artefact of elution behavior because: (i) their elution behavior in Sephadex gel filtration is not altered by the presence of formic acid or NaDodSO4; (ii) the yield of these fragments is greatly increased by sarcoma membrane particles; (iii) this increase in yield is prevented by protease inhibitors. The larger aggregates which can be formed spontaneously in aqueous solutions of fragments obtained from the Al subunit are very different from Al, since the former are dissociated by NaDodSO4 and the latter is not.
Aggregation behavior is shown by the A subunit as well as the small fragments. This can be accompanied by relative loss of adenylate-cyclase-activating ability which is recovered following exposure of the aggregates to NaDodSO4. It is intriguing that the smallest fragment which retains adenylate-cyclaseactivating ability also retains antigenic determinants found in the holotoxin in a peptide which may be no larger than 12 amino acid residues. Further studies will be needed for the purification, amino acid composition and sequence, and specific activity and the stoichiometric ratios between Al and the smallest fragments. These data should further enhance understanding of the mechanism of action of cholera toxin and adenylate cyclase regulation.
